GB9509461D0 - DNA molecules and constructs and their use in the treatment of mastitis - Google Patents

DNA molecules and constructs and their use in the treatment of mastitis

Info

Publication number
GB9509461D0
GB9509461D0 GBGB9509461.1A GB9509461A GB9509461D0 GB 9509461 D0 GB9509461 D0 GB 9509461D0 GB 9509461 A GB9509461 A GB 9509461A GB 9509461 D0 GB9509461 D0 GB 9509461D0
Authority
GB
United Kingdom
Prior art keywords
mastitis
constructs
treatment
dna molecules
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9509461.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNOVA
Original Assignee
IMMUNOVA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNOVA filed Critical IMMUNOVA
Priority to GBGB9509461.1A priority Critical patent/GB9509461D0/en
Publication of GB9509461D0 publication Critical patent/GB9509461D0/en
Priority to PCT/CA1996/000297 priority patent/WO1996035793A1/en
Priority to JP8533627A priority patent/JPH11505113A/en
Priority to NZ336371A priority patent/NZ336371A/en
Priority to CA002220472A priority patent/CA2220472A1/en
Priority to EP96913403A priority patent/EP0828839A1/en
Priority to NZ307139A priority patent/NZ307139A/en
Priority to AU56416/96A priority patent/AU724905B2/en
Priority to MXPA/A/1997/008615A priority patent/MXPA97008615A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/102—Caprine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/103—Ovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
GBGB9509461.1A 1995-05-10 1995-05-10 DNA molecules and constructs and their use in the treatment of mastitis Pending GB9509461D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB9509461.1A GB9509461D0 (en) 1995-05-10 1995-05-10 DNA molecules and constructs and their use in the treatment of mastitis
PCT/CA1996/000297 WO1996035793A1 (en) 1995-05-10 1996-05-10 Animal gene therapy
JP8533627A JPH11505113A (en) 1995-05-10 1996-05-10 Animal gene therapy
NZ336371A NZ336371A (en) 1995-05-10 1996-05-10 Human gene therapy using DNA/RNA cassette expression systems
CA002220472A CA2220472A1 (en) 1995-05-10 1996-05-10 Genetically treated animals
EP96913403A EP0828839A1 (en) 1995-05-10 1996-05-10 Animal gene therapy
NZ307139A NZ307139A (en) 1995-05-10 1996-05-10 Method of genetically treating and preventing mastitis and other diseases in animals.
AU56416/96A AU724905B2 (en) 1995-05-10 1996-05-10 Animal gene therapy
MXPA/A/1997/008615A MXPA97008615A (en) 1995-05-10 1997-11-07 Genes therapy anima

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509461.1A GB9509461D0 (en) 1995-05-10 1995-05-10 DNA molecules and constructs and their use in the treatment of mastitis

Publications (1)

Publication Number Publication Date
GB9509461D0 true GB9509461D0 (en) 1995-07-05

Family

ID=10774245

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9509461.1A Pending GB9509461D0 (en) 1995-05-10 1995-05-10 DNA molecules and constructs and their use in the treatment of mastitis

Country Status (7)

Country Link
EP (1) EP0828839A1 (en)
JP (1) JPH11505113A (en)
AU (1) AU724905B2 (en)
CA (1) CA2220472A1 (en)
GB (1) GB9509461D0 (en)
NZ (1) NZ307139A (en)
WO (1) WO1996035793A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114118A (en) * 1996-09-20 2000-09-05 Texas A&M University System Method of identification of animals resistant or susceptible to disease such as ruminant brucellosis, tuberculosis, paratuberculosis and salmonellosis
USRE44266E1 (en) * 1997-01-17 2013-06-04 The Scripps Research Institute Expression of eukaryotic polypeptides in chloroplasts
AU9160398A (en) * 1997-07-22 1999-02-16 Novimmune Sa Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
CA2211293A1 (en) * 1997-07-23 1999-01-23 Immunova Ltee Recombinant lysostaphin analogs
US7091332B1 (en) 1998-06-22 2006-08-15 University Of Vermont Treatment of staphylococcus infections
US6875903B2 (en) 1998-06-22 2005-04-05 University Of Vermont Treatment of Staphylococcus infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0832981A1 (en) * 1987-02-17 1998-04-01 Pharming B.V. DNA sequences to target proteins to the mammary gland for efficient secretion
PH30997A (en) * 1990-03-12 1997-12-23 Ciba Geigy Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
AU650459B2 (en) * 1990-05-25 1994-06-23 Washington State University Research Foundation Method of inducing plant defense mechanisms
EP0652889A4 (en) * 1992-06-15 1997-05-07 Gene Pharming Europ Bv Production of recombinant polypeptides by bovine species and transgenic methods.

Also Published As

Publication number Publication date
AU5641696A (en) 1996-11-29
MX9708615A (en) 1998-06-28
WO1996035793A1 (en) 1996-11-14
NZ307139A (en) 1999-08-30
EP0828839A1 (en) 1998-03-18
JPH11505113A (en) 1999-05-18
CA2220472A1 (en) 1996-11-14
AU724905B2 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
HUP9801216A3 (en) Dna molecules, preparation thereof and use thereof in gene therapy
NZ289028A (en) Use of antisense nucleic acids in the treatment of skin disease
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
GB9214857D0 (en) Human nucleic acid fragments and their use
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
AU7623096A (en) Use of epinastine in the treatment of pain
PL319021A1 (en) Body weight modulators, appropriate nucleic acid and proteins and their diagnostic and therapeutic application
HUP9901908A3 (en) P16 expression constructs and their application in cancer therapy
AU2603895A (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
HUT77108A (en) Dna sequence and its use
AU1598599A (en) Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
GB9509461D0 (en) DNA molecules and constructs and their use in the treatment of mastitis
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
GB9518154D0 (en) Oligonucleotides and their use
GB9415129D0 (en) Oligonucleotides and their use
AU3838695A (en) Use of the bio-spectrum in animal embryo-engineering
GB9501978D0 (en) Nucleic acids, proteins and their use in therapy
AUPN650795A0 (en) Encapsulated substances and their use in the treatment of animals
AUPM932194A0 (en) Encapsulated substances and their use in the treatment of animals
GB9616504D0 (en) Therapeutic product and its use
AU4861996A (en) A proliferation-inhibiting gene sequence and its use in the treatment of cancer and other diseases
GB9405872D0 (en) Biological process and formulation
AU5279996A (en) Antibodies and their use in cancer therapy and diagnosis
GB9824091D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0205963D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases